EXPLORE!

Government seeks more expert opinion on Covaxin for pediatric use

  758 Views

#Hospital Medicine  #Infectious Diseases  #Pathology and Lab Medicine  #Pharmacist  #Public Health  #Pulmonary Medicine 

eMediNexus    17 October 2021

The government is moving ahead carefully on giving approval to Covaxin for use in children, particularly for those as young as 2 years.

The subject expert committee (SEC) of the Drugs Controller General of India (DCGI) had considered Bharat Biotech’s data from clinical trials conducted among children in three different age groups, including 2-6 years, 6-12 years and 12-18 years, and had recommended that DCGI give emergency use authorization for pediatric use of the vaccine in the country. Health minister Mansukh Mandaviya; however, said that there is a need to move cautiously, and consider all the safety aspects. The DCGI will seek more expert opinion before authorizing the vaccine. A senior official of the health ministry said that all aspects, in particular, adverse events following immunization (AEFI), will be considered before giving a go-ahead in India… (ET Healthworld, October 15, 2021)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.